A detailed history of Operose Advisors LLC transactions in Haleon PLC stock. As of the latest transaction made, Operose Advisors LLC holds 1,096 shares of HLN stock, worth $10,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,096
Previous 1,096 -0.0%
Holding current value
$10,631
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$8.02 - $8.67 $8,789 - $9,502
1,096 New
1,096 $9,000
Q3 2023

Nov 13, 2023

BUY
$7.85 - $8.94 $8,603 - $9,798
1,096 New
1,096 $9,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.